Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers

por Capetti, Amedeo F., Borgonovo, Fabio, Morena, Valentina, Lupo, Angelica, Cossu, Maria Vittoria, Passerini, Matteo, Dedivitiis, Gianfranco, Rizzardini, Giuliano
Publicado 2020

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?

por Capetti, Amedeo F, Atzori, Chiara, Cossu, Maria V, Ciccullo, Arturo, Restelli, Sibilla, Piscaglia, Marco, Gallazzi, Ilaria, Meraviglia, Paola, DiGiambenedetto, Simona, Rizzardini, Giuliano
Publicado 2019

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study

por Borgonovo, Fabio, Passerini, Matteo, Piscaglia, Marco, Morena, Valentina, Giacomelli, Andrea, Oreni, Letizia, Dedivitiis, Gianfranco, Lupo, Angelica, Falvella, Stefania, Cossu, Maria Vittoria, Capetti, Amedeo F.
Publicado 2021

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG

por Capetti, Amedeo F., Borgonovo, Fabio, Mileto, Davide, Gagliardi, Gloria, Mariani, Chiara, Lupo, Angelica, Dedivitiis, Gianfranco, Meraviglia, Paola, Pellicciotta, Martina, Armiento, Luciana, Cossu, Maria V., Rizzardini, Giuliano
Publicado 2021

Persistence of Long-COVID symptoms in a heterogenous prospective cohort

por Mariani, Chiara, Borgonovo, Fabio, Capetti, Amedeo F, Oreni, Letizia, Cossu, Maria Vittoria, Pellicciotta, Martina, Armiento, Luciana, Bocchio, Simona, Dedivitiis, Gianfranco, Lupo, Angelica, Galli, Massimo, Rizzardini, Giuliano
Publicado 2022

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort

por Capetti, Amedeo F., Sterrantino, Gaetana, Cossu, Maria Vittoria, Orofino, GianCarlo, Barbarini, Giorgio, De Socio, Giuseppe V., Di Giambenedetto, Simona, Di Biagio, Antonio, Celesia, Benedetto M., Argenteri, Barbara, Rizzardini, Giuliano
Publicado 2016

Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects

por Borgonovo, Fabio, Stangalini, Carlo Alberto, Tinelli, Carmine, Mariani, Chiara, Mileto, Davide, Cossu, Maria Vittoria, Abbati, Laura, Bilardo, Lara, Gagliardi, Gloria, Cutrera, Miriam, Pellicciotta, Martina, Armiento, Luciana, Dedivitiis, Gianfranco, Capetti, Amedeo F., Rizzardini, Giuliano
Publicado 2022

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data

por Capetti, Amedeo F., Cossu, Maria Vittoria, Orofino, Giancarlo, Sterrantino, Gaetana, Cenderello, Giovanni, De Socio, Giuseppe V., Cattelan, Anna Maria, Soria, Alessandro, Rusconi, Stefano, Riccardi, Niccolò, Baldin, Gian Maria, Niero, Fosca P., Barbarini, Giorgio, Rizzardini, Giuliano
Publicado 2017